Reports for TEVA-BUPRENORPHINE/NALOXONE
Brand name
TEVA-BUPRENORPHINE/NALOXONE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02453916 |
Ingredients
NALOXONE BUPRENORPHINE |
Ingredient Strength
2 MG 8 MG |
ATC Code
N07BCN07BC |
ATC Descriptor
DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2024-03-07 | 2024-06-27 | 221537 |
Showing 1 to 3 of 3
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0